TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Yesterday

NL

Article

EBCapitalMarkets published an article 10:10 AM

Walgreen Company Earnings: Baby Boomers Drive Results Higher

Walgreen Company's sales and earnings grew in the past year as more Americans signed up for Medicare Part D plans.

Thu Sep 25

NL

Article

EBCapitalMarkets published an article 12:22 PM

The 5 Best Biotech Stocks in 2014...so far

Here's why these five companies are biotech's top performers this year.

NL

Article

EBCapitalMarkets published an article 9:30 AM

Warren Buffett's $90 Million Bet on Risk

Warren Buffett loves risk, assuming of course that he can identify and price it. That's likely why he remains a fan of this risk analytics company.

Wed Sep 24

NL

Article

EBCapitalMarkets published an article 5:07 PM

The Next Blue Chip Stocks: WellPoint Inc

WellPoint's growth from healthcare reform and ageing seniors positions it perfectly to become one of America's most important companies.

NL

Article

EBCapitalMarkets published an article 1:35 PM

Is Medicare Costing You More?

Medicare parts B and D include premium adjustments that increase their cost to high income earners, but if seniors income changes the adjustment can be removed.

NL

Article

EBCapitalMarkets published an article 11:17 AM

Gilead Sciences, Inc. Takes Aim at Bristol-Myers Squibb

Gilead Sciences has filed for approval of its next generation hepatitis C drug in Japan in a move that will challenge Bristol-Myers first to market advantage.

Tue Sep 23

NL

Article

EBCapitalMarkets published an article 7:43 PM

1 Marijuana Stock You Can Buy Right Now

While many medical marijuana stocks are trading at jaw-dropping valuations, Insys may be a relative value given the potential approval of its synthetic THC drug, dronabinol.

NL

Article

EBCapitalMarkets published an article 4:15 PM

Is It Finally Time to Buy Dividend Stock GlaxoSmithKline plc?

GlaxoSmithKline has been stumbling because of patent expiration and sliding sales for its top-selling asthma drug, Advair, but that may not mean it's time to buy.

NL

Article

EBCapitalMarkets published an article 12:16 PM

Is Walgreen Company a Value Stock Following Its 20% Tumble?

Walgreen's decision not to do a tax inversion has sent shares stumbling, but that may be creating value for investors looking for a bargain.

NL

Article

EBCapitalMarkets published an article 11:11 AM

Not Even a Weight Loss Drug Could Stop Orexigen Therapeutics, Inc. From Dropping 20% in 2014

Despite winning FDA approval for the weight loss drug Contrave, Orexigen's shares have tumbled this year.

NL

Article

EBCapitalMarkets published an article 9:55 AM

Why Geron Corporation Stock Is Down a Shocking 52% in 2014

The FDA's clinical hold on imetelstat has rocked Geron's shares this year.

Mon Sep 22

NL

Article

EBCapitalMarkets published an article 10:16 AM

The Next Blue Chip Stocks: Gilead Sciences, Inc.

Gilead Sciences robust HIV drug franchise and blockbuster hepatitis C drugs position it for coveted blue chip status.

Sun Sep 21

NL

Article

EBCapitalMarkets published an article 2:43 PM

The Insurers Obamacare Really Helps May Surprise You

Its private Medicaid insurers like Molina, not national insurers like UniteHealth Group, that are seeing the biggest jump in profits thanks to the Affordable Care Act.

Sat Sep 20

NL

Article

EBCapitalMarkets published an article 1:52 PM

7 Things Peyton Manning Can Teach Us About Investing

Peyton Manning's net worth is north of $100 million, so could lessons he's learned playing in the NFL help investors become wealthy, too?

Tue Sep 16

NL

Article

EBCapitalMarkets published an article 7:49 PM

3 Best Stocks for Investing in Biotech

Gilead Sciences, Celgene Corp, and BioMarin are three biotech industry companies that are revolutionizing how doctors treat patients.

NL

Article

EBCapitalMarkets published an article 4:28 PM

Is There Hope for Rite Aid Corporation Stock After It's Horrendous Quarter?

Rite Aid is stumbling due to falling generic drug margins, yet shares are clinging to a year-to-date gain.

NL

Article

EBCapitalMarkets published an article 3:52 PM

Rite Aid Corporation Stock Earnings: 3 Key Things to Watch

Here are three important questions Rite Aid needs to address during its earnings conference call on September 18th.

NL

Article

EBCapitalMarkets published an article 12:25 PM

Why CVS Health Corporation Is Up 14.8% in 2014

CVS Health's shift toward primary care services is boosting both sales and share prices.

NL

Article

EBCapitalMarkets published an article 10:07 AM

Why Amgen Inc.'s Stock Is up 23% in 2014

Amgen is rallying on hope surrounding a new class of PCSK9 inhibitors designed to reduce bad cholesterol.

Mon Sep 15

NL

Article

EBCapitalMarkets published an article 9:49 AM

Why Is Gilead Sciences, Inc. Stock Offering This Drug for Cheap?

Gilead Sciences will collect royalties on generic Sovaldi beginning as early as next year, even as it launches its next generation hepatitis C drug here in the United States.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 21.24
Player Rank 59105 out of 75039
Score -215.76
Score Change Today -15.08
Accuracy 32.35%
Active Picks 34
Total Picks 34
Best Pick GILD (+65.66)
Worst Pick WFM (-47.57)
Average Score per Pick -6.35
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts